Novo Holdings, which controls obesity drugmaker Novo Nordisk , is sharpening its focus on India, targeting single-specialty hospitals and contract drugmakers to tap high-growth healthcare segments, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback